摘要
目的 观察参附注射液辅助治疗急性心肌梗死合并心源性休克的临床效果.方法 选择急性心肌梗死合并心源性休克患者60例,依照随机数字表法将其分为2组,对照组（n=30）给予常规西医综合治疗,观察组（n=30）在对照组治疗基础上给予参附注射液,首次60 ml静脉注射,而后5 ml维持泵入,观察24～48 h,对比分析两组患者的临床效果.结果 观察组总有效率高于对照组（P＜0.05）;两组患者治疗后的心率、血压、尿量指标较治疗前有显著改善（P＜0.05或P＜0.01）,且观察组的改善情况优于对照组（P＜0.05）.结论 参附注射液辅助治疗急性心肌梗死合并心源性休克患者的临床效果显著,建议临床推广应用.
Objective To observe the clinical effects of using Shenfu injection as an auxiliary therapeutic treatment for the acute myocardial infarction complicating cardiac shock. Methods 60 patients with- acute myocardial infarction complicating cardiac shock were randomly divided into 2 groups. Patients in the control group （n=30）received treatment of conventional western medicine combined treatment, while patients in the observational group（n= 30）were treated with both conventional western medicine combined treatment and Shenfu injection. The patients in the observational group were treated with intravenous injection with Shenfu injection for 60ml, and keep injecting for 5ml per hour. The clinical effects for 24 to 48 hours were obseved. Results The treatment effect rate of the observation group was higher than that of the control group（P〈0.05）. The heart rate, blood pressure and urine of both groups were improved after treating（P 〈0.05 or P〈0. 01）. The improving effects of the observational group were better than that of the control group（P〈 0.05）. Conclusion The effects of using the Shenfu injection as an auxiliary therapeutic treatment for treating the acute myocardial infarction complicating cardiac shock is significant.
出处
《西部医学》
2013年第12期1833-1834,1839,共3页
Medical Journal of West China
关键词
参附注射液
急性心肌梗死
心源性休克
临床效果
对比研究
Shenfu Injection
Acute myocardial infarction
Cardiogenic shock
Clinical Effects
Control study
